Impact of sustained virologic response on chronic kidney disease progression in hepatitis C

AIM: To determine how sustained virological response at 12 wk (SVR12) with direct acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) infection affects chronic kidney disease (CKD) progression. METHODS: A retrospective analysis was performed in patients aged ≥ 18 years treated for...

Descripción completa

Detalles Bibliográficos
Autores principales: Aby, Elizabeth S, Dong, Tien S, Kawamoto, Jenna, Pisegna, Joseph R, Benhammou, Jihane N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756725/
https://www.ncbi.nlm.nih.gov/pubmed/29359019
http://dx.doi.org/10.4254/wjh.v9.i36.1352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756725/
https://www.ncbi.nlm.nih.gov/pubmed/29359019
http://dx.doi.org/10.4254/wjh.v9.i36.1352

Ejemplares similares